SMTL ID : 8eiq.1

The complex of phosphorylated human delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) with Trikafta [elexacaftor (VX-445), tezacaftor (VX-661), ivacaftor (VX-770)] and ATP/Mg

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-mer

Ligands

2 x MG: MAGNESIUM ION(Non-covalent)

MG.1: 3 residues within 4Å: Chain A: T.465, Q.493 Ligands: ATP.3 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.465 MG.2: 4 residues within 4Å: Chain A: S.1250, Q.1290, D.1369 Ligands: ATP.4 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:S.1250

2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.3: 16 residues within 4Å: Chain A: W.401, T.460, G.461, A.462, G.463, K.464, T.465, S.466, Q.493, Q.1329, C.1343, V.1344, S.1346, H.1347, G.1348 Ligands: MG.1 17 PLIP interactions: 17 interactions with chain A Hydrogen bonds: A:G.461, A:A.462, A:G.463, A:K.464, A:T.465, A:T.465, A:S.466, A:Q.493, A:Q.493, A:Q.1329, A:C.1343, A:H.1347, A:G.1348 Salt bridges: A:K.464, A:K.464 pi-Stacking: A:W.401, A:W.401 ATP.4: 17 residues within 4Å: Chain A: F.532, T.546, S.548, G.549, G.550, Q.551, Y.1218, T.1245, G.1246, S.1247, G.1248, K.1249, S.1250, T.1251, Q.1290, H.1401 Ligands: MG.2 22 PLIP interactions: 22 interactions with chain A Hydrogen bonds: A:T.546, A:S.548, A:S.548, A:G.549, A:G.550, A:Q.551, A:Q.551, A:G.1246, A:G.1246, A:S.1247, A:G.1248, A:K.1249, A:S.1250, A:S.1250, A:S.1250, A:T.1251, A:T.1251, A:Q.1290 Salt bridges: A:K.1249, A:K.1249 pi-Stacking: A:Y.1218, A:Y.1218

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.5: 5 residues within 4Å: Chain A: Y.89, L.206, L.210, G.213, L.214 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.210, A:L.214

1 x D12: DODECANE(Non-covalent)

D12.6: 2 residues within 4Å: Chain A: W.361 Ligands: CV6.9 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.361, A:W.361

1 x VX7: N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide(Non-covalent)

VX7.7: 7 residues within 4Å: Chain A: F.305, S.308, A.309, F.312, G.929, F.930, F.931 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.309, A:F.931 Hydrogen bonds: A:S.308, A:F.930 pi-Stacking: A:F.312, A:F.930

1 x WJX: (6P)-N-(1,3-dimethyl-1H-pyrazole-4-sulfonyl)-6-[3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl]-2-[(4S)-2,2,4-trimethylpyrrolidin-1-yl]pyridine-3-carboxamide(Non-covalent)

WJX.8: 9 residues within 4Å: Chain A: S.18, R.21, L.24, I.132, Y.1031, W.1097, R.1101, M.1104, V.1107 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:V.1107 Hydrogen bonds: A:R.21, A:R.1101

1 x CV6: Tezacaftor(Non-covalent)

CV6.9: 14 residues within 4Å: Chain A: I.70, N.71, L.73, R.74, F.77, F.78, F.81, M.152, L.195, A.198, T.360, W.361, S.364 Ligands: D12.6 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.70, A:R.74, A:F.77, A:F.78, A:F.78, A:F.81 Hydrogen bonds: A:N.71, A:R.74, A:S.364 pi-Stacking: A:F.81 pi-Cation interactions: A:R.74

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Fiedorczuk, K. et al., Molecular structures reveal synergistic rescue of Delta 508 CFTR by Trikafta modulators. Science (2022)

Release Date

2022-10-19

Peptides

Cystic fibrosis transmembrane conductance regulator: A
Cystic fibrosis transmembrane conductance regulator: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Cystic fibrosis transmembrane conductance regulator

Cystic fibrosis transmembrane conductance regulator

Related Entries With Identical Sequence